TRUEMETHYL
DEAD

Serial Number

85873436

Owner

Cambridge EpiGenetix Limited

Attorney

Rebecca A. Liebowitz

Filing Date

Mar 12, 2013

Add to watchlist:

No watchlists yet
View on USPTO

TRUEMETHYL Trademark

Serial Number: 85873436 • Registration: 4857461

TRUEMETHYL is a trademark filed by Cambridge EpiGenetix Limited on March 12, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Cambridge EpiGenetix Limited

B400, The Trinity Building
Saffron Walden CB101XL , GB

Entity Type: 99

BIOMODAL LIMITED

B400, THE TRINITY BUILDING CHESTERFORD
SAFFRON WALDEN CB10 1XL , GB

Entity Type: 99

Trademark Details

Filing Date

March 12, 2013

Registration Date

November 24, 2015

Published for Opposition

May 5, 2015

Cancellation Date

June 5, 2026

Goods & Services

Apparatus for clinical diagnosis used to identify, sequence and measure DNA, RNA and other nucleic acids; diagnostic apparatus for the detection of mutations in genes, genetic predispositions, and changes in epigenetic modifications, namely, arrays, sequencers and genotyping systems comprised of sample tubes, vials, reagents in the nature of bisulfite, magnetic beads, oligonucleotides, DNA polymerases and restriction digest enzymes, washes in the nature of acetonitrile washes and ethanol washes, solutions in the nature of oxidation solution, bisulfite diluent, bisulfite additive, magnetic bead binding buffer, desulfonation buffer and elution buffer, solvents in the nature of ethanol, isopropanol and acetonitrile, operating software, electrical sensors, optical sensors, and chemical sensors, all the foregoing sold as a unit

[ Pharmaceutical and veterinary preparations for use in the identification of genomic markers and the diagnosis and treatment of diseases or conditions that are caused by or exacerbated by genetic factors; ] chemical and biological preparations for medical or veterinary purposes for use in the identification of genomic markers and the diagnosis [ and treatment ] of diseases or conditions that are caused by or exacerbated by genetic factors; diagnostic substances for medical and veterinary use for use in the identification of genomic markers and the diagnosis [ and treatment ] of diseases or conditions that are caused by or exacerbated by genetic factors; chemical and biological preparations for detecting mutations in genes and genetic predispositions for medical or veterinary purposes; [ stem cells for medical or veterinary purposes; ] biological and chemical reagents for detecting mutations in genes, genetic conditions, genomic sequences and genetic factors; clinical, medical and medical diagnostic reagents [ ; sedatives ; vaccines; fungicides; herbicides ]

[ Medical and veterinary services; medical and veterinary services relating to DNA, genetics and genetic testing; clinical medical diagnostic services, namely, DNA and genetic testing consulting, and counseling; medical and surgical diagnostic services; personalized medical services tailored to patients based on genetic or other information; health care; medical and healthcare clinic services; physical therapy; pharmacy advice; hospitals; medical equipment rental; professional consultancy and advisory services relating to all of the aforementioned services ]

[ Scientific and technological services, namely, research and analysis relating to the identification of genomic markers, genetic conditions and the diagnosis and treatment of genetic conditions and genetic predispositions; industrial analysis and research services in the field of identification of genomic markers and the diagnosis and treatment of diseases with a genetic component; genetic and epigenetic analysis services; DNA modification analysis services, including but not limited to methylation, hydroxymethylation, formylation and carboxylation; research and development in the field of biotechnology, biology and chemistry; research and development services in the field of genetics; genome research for scientific purposes; stem cell research for scientific purposes; gene therapy research for scientific purposes; genetic engineering services; pharmaceutical research and development; research services for the development of new products; design and development of computer hardware and software; provision of information and data relating to medical and veterinary research and development; professional consultancy and advisory services relating to all of the aforementioned services ]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jun 5, 2026 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 24, 2024 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 27, 2024 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 24, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2023 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 11, 2022 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 11, 2022 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 10, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 19, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 24, 2020 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 24, 2015 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 19, 2015 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 9, 2015 AITU
NOTICE OF ALLOWANCE CANCELLED
Sep 23, 2015 IUCN
PAPER RECEIVED
Sep 23, 2015 MAIL
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 30, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 30, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 25, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 25, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 25, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 25, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2015 CRFA
ASSIGNED TO LIE
Mar 14, 2015 ALIE
PAPER RECEIVED
Mar 6, 2015 MAIL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 6, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 6, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 6, 2014 CNRT
AMENDMENT FROM APPLICANT ENTERED
Aug 18, 2014 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2014 CRFA
PAPER RECEIVED
Aug 6, 2014 MAIL
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 10, 2014 GNFN
FINAL REFUSAL E-MAILED
Feb 10, 2014 GNFR
FINAL REFUSAL WRITTEN
Feb 10, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2014 CRFA
ASSIGNED TO LIE
Jan 8, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 21, 2013 GNRN
NON-FINAL ACTION E-MAILED
Jun 21, 2013 GNRT
NON-FINAL ACTION WRITTEN
Jun 21, 2013 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2013 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Mar 16, 2013 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 15, 2013 NWOS
NEW APPLICATION ENTERED
Mar 15, 2013 NWAP